Zoladex LA

Medicinal product

(Invented) name

Zoladex LA

Active substance (s)

Goserelinas

Strength

10,8 mg

Pharmaceutical form

implantas

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02AE03, Goserelin

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

1997-06-06

Date of renewal

2007-12-20

Documents

0813 Pakuotės lapelis 10,8mg 2023 07 28.docx

0813 Zoladex LA 10,8mg II PL 2023 07 28.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Vienos dozės užpildytame švirkšte (implante) yra	1 vnt.
Goserelinas	10,8 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
10508	2050	1002050	užpildytas švirkštas	N1		Receptinis	LT/1/94/0813/002	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2007-12-20	Perregistruotas
1997-06-06	Registruotas